FYERS
Home
/
Stocks
/
Profit Loss
/
Fischer Medical Ventures Profit & Loss

Fischer Medical Ventures Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
₹82 Cr₹98 Cr₹101 Cr₹86 Cr₹23 Cr₹49 Cr₹12 Cr₹40 Cr₹10 Cr₹21 Cr
₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹7 Cr₹15 L₹38 L₹22 L₹74 L₹47 L
₹83 Cr₹99 Cr₹102 Cr₹89 Cr₹31 Cr₹49 Cr₹12 Cr₹40 Cr₹11 Cr₹21 Cr
₹72 Cr₹98 Cr₹80 Cr₹71 Cr₹20 Cr₹47 Cr₹12 Cr₹39 Cr₹11 Cr₹18 Cr
₹13 Cr₹2 Cr₹23 Cr₹19 Cr₹12 Cr₹3 Cr₹88 L₹72 L₹48 L₹3 Cr
₹4 Cr₹4 Cr₹64 L₹92 L₹66 L₹23 L₹7 L₹5 L₹13 L₹5 L
₹8 Cr-₹2 Cr₹21 Cr₹17 Cr₹10 Cr₹2 Cr₹25 L₹38 L₹8 L₹3 Cr
₹4 Cr-₹7 Cr₹19 Cr₹14 Cr₹5 Cr₹1 Cr-₹17 L₹46 L-₹12 L₹3 Cr

Share Price Live Stats

Open (₹)37.44
Volume (₹)98,375.00
High (₹)37.62
Upper Circuit44.43
Low (₹)36.36
Lower Circuit29.63
Prev Close37.03
52W High (₹)124.70
Price36.45
52W Low (₹)31.05

Share Market Cap & Key Ratios Overview

M.Cap (₹)2601.90 Cr
Div. Yield (%)0.00
PE Ratio87.24
Debt to Equity0.20
Price to Book18.64
Book Value4.82
EPS (TTM)0.43
Face Value1.00
ROE (%)0.62

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
ADANIENTNSE
PREMIERENENSE
AEGISLOGNSE
CPPLUSNSE
REDINGTONNSE
HONASANSE
LLOYDSENTNSE
SGMARTNSE
MMTCNSE
ENTERONSE
FISCHERNSE
LTP
1W Low
1W High
Market cap (₹)
2942.2-226.3 (-7.14%)
2830.50
3165
3,90,684Cr
1002.1-11.8 (-1.16%)
995.10
1036.30
45,486Cr
1273.6-15.8 (-1.23%)
1180
1327.30
45,144Cr
3748.6+172 (4.81%)
3460.20
3797.90
44,346Cr
368.5+2.5 (0.68%)
343.70
378.80
29,113Cr
480.5+9.85 (2.09%)
464.60
492.60
15,566Cr
73.12-0.41 (-0.56%)
69.51
74.69
10,984Cr
821.2+31.9 (4.04%)
785.50
859.95
10,266Cr
64.96+1.89 (3.00%)
61.41
66.20
9,342Cr
1843.9+35.3 (1.95%)
1742.60
1868.90
8,041Cr
36.45+1.01 (2.85%)
34.67
38.50
2,602Cr

Key Highlights of Fischer Medical Ventures Ltd’s P&L

In 2025-03-31, Fischer Medical Ventures Ltd reported total revenue of ₹112.19Cr, compared with ₹21.48Cr in 2024-03-31, reflecting Fischer Medical Ventures Ltd turnover.

Depreciation was ₹1.63Cr and finance costs were ₹49.36Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹2.22Cr in 2025-03-31 as compared to ₹2.11Cr in 2024-03-31.

Net Profit (PAT) was ₹1.48Cr in 2025-03-31 compared with ₹1.38Cr in 2024-03-31.

Earnings per share (EPS) were ₹0.23 in 2025-03-31, compared with ₹0.26 in 2024-03-31.